Canlyniadau Chwilio - Kosuke Hashimoto

Unveiling unique expression patterns of D20S16 satellite DNA in human embryonic development gan Yajie Hu, Kenji Mizuguchi, Kosuke Hashimoto

Cael y testun llawn

Excitatory GABA receptors shape locomotor circuit organization in C. elegans gan Xingran Wang, Kenji Mizuguchi, Kosuke Hashimoto

Cael y testun llawn

Optimizing Tinnitus Management: The Important Role of Hearing Aids with Sound Generators gan Yuki Kosugi, Toru Miwa, Yuka Haruta, Kosuke Hashimoto, Shoko Kato

Cael y testun llawn

Attention network for predicting T-cell receptor–peptide binding can associate attention with interpretable protein structural properties gan Kyohei Koyama, Kyohei Koyama, Kyohei Koyama, Kosuke Hashimoto, Chioko Nagao, Kenji Mizuguchi, Kenji Mizuguchi, Kenji Mizuguchi

Cael y testun llawn

Synchronous occurrence of interstitial lung disease and ICANS after tarlatamab initiation in recurrent small-cell lung cancer gan Masakazu Takahara, Atsuto Mouri, Ou Yamaguchi, Tatsuhiko Uno, Kosuke Hashimoto, Hisao Imai, Hiroshi Kagamu, Kyoichi Kaira

Cael y testun llawn

Integrating spatial and chemical information enhances differentiation of non-alcoholic steatohepatitis states in Raman imaging gan Ryoya Kondo, Yuta Mizuno, Kentaro Mochizuki, Kosuke Hashimoto, Jean-Emmanuel Clément, Yasuaki Kumamoto, Katsumasa Fujita, Yoshinori Harada, Tamiki Komatsuzaki

Cael y testun llawn

Clinical significance of visual cardiac 18F-FDG uptake in advanced non-small cell lung cancer gan Kosuke Hashimoto, Kyoichi Kaira, Hisao Imai, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Yu Miura, Kunihiko Kobayashi, Hiroshi Kagamu, Ichiei Kuji

Cael y testun llawn

Th7R predicts chemo-immunotherapy response and survival in small cell lung cancer gan Shota Takei, Ayako Shiono, Satoshi Yamasaki, Ou Yamaguchi, Atsuto Mouri, Yu Miura, Kosuke Hashimoto, Hisao Imai, Kyoichi Kaira, Hiroshi Kagamu

Cael y testun llawn

Early FMISO PET changes as exploratory predictors of immune checkpoint inhibitor response in advanced lung cancer: a pilot study gan Kosuke Hashimoto, Kyoichi Kaira, Hisao Imai, Atsuto Mouri, Ayako Shiono, Yu Miura, Ou Yamaguchi, Tomonori Kawasaki, Hiroshi Kagamu, Ichiei Kuji

Cael y testun llawn

G-CSF–producing pulmonary sarcomatoid carcinoma treated with chemoradiotherapy followed by durvalumab: a case report gan Naohito Hashimoto, Kyoichi Kaira, Tatsuhiko Uno, Kosuke Hashimoto, Atsuto Mouri, Ou Yamaguchi, Hisao Imai, Naoko Shojiguchi, Taku Homma, Hiroshi Kagamu

Cael y testun llawn

Correlation between T cell immunity and the duration of EGFR-TKI resistance acquisition in patients harboring EGFR mutations gan Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Satoshi Yamasaki, Fuyumi Nishihara, Hisao Imai, Kunihiko Kobayashi, Hiroshi Kagamu

Cael y testun llawn

Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies i... gan Takahiro Uchida, Kyoichi Kaira, Ou Yamaguchi, Atsuto Mouri, Ayako Shiono, Yu Miura, Kosuke Hashimoto, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu

Cael y testun llawn

Improved efficacy of ramucirumab plus docetaxel after nivolumab failure in previously treated non‐small cell lung cancer patients gan Ayako Shiono, Kyoichi Kaira, Atsuto Mouri, Ou Yamaguchi, Kosuke Hashimoto, Takahiro Uchida, Yu Miura, Fuyumi Nishihara, Yoshitake Murayama, Kunihiko Kobayashi, Hiroshi Kagamu

Cael y testun llawn

Efficacy and Feasibility of Programmed Death-1/Programmed Death Ligand-1 Blockade Therapy in Non-Small Cell Lung Cancer Patients With High Antinuclear Antibody Titers gan Atsuto Mouri, Kyoichi Kaira, Ou Yamaguchi, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Shun Shinomiya, Tomoe Akagami, Hisao Imai, Kunihiko Kobayashi, Hiroshi Kagamu

Cael y testun llawn

Pretreatment body mass index predicts survival among patients administered nivolumab monotherapy for pretreated non‐small cell lung cancer gan Hisao Imai, Erika Naito, Ou Yamaguchi, Kosuke Hashimoto, Hidetoshi Iemura, Yu Miura, Ayako Shiono, Atsuto Mouri, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu

Cael y testun llawn

Concurrent Chemoradiotherapy with Daily Low-Dose Carboplatin in Older Patients with Unresectable Locally Advanced Non-Small-Cell Lung Cancer: Clinical Outcomes and Prognostic Signi... gan Yu Miura, Hisao Imai, Satoshi Endo, Kosuke Hashimoto, Ou Yamaguchi, Atsuto Mouri, Ken Masubuchi, Takeshi Masubuchi, Yuka Fujita, Shingo Kato, Hiroshi Kagamu, Kyoichi Kaira

Cael y testun llawn

Prognostic relevance of TROP2 expression in patients with non-small cell lung cancer receiving immunotherapy gan Naohito Hashimoto, Shota Takei, Kyoichi Kaira, Hisao Imai, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Atsuto Mouri, Kunihiko Kobayashi, Mei Hamda, Hiroshi Kagamu

Cael y testun llawn

Efficacy and safety of first-line nivolumab plus ipilimumab treatment in elderly patients (aged ≥ 75 years) with non-small cell lung cancer gan Satoshi Endo, Hisao Imai, Atsuto Mouri, Kasumi Tsukamoto, Kenji Masaki, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Junichi Nakagawa, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu

Cael y testun llawn

A Real‐Word Analysis of the Correlation Between Clinical Efficacy and Predictive Factors of Immune‐Related Adverse Events in Patients With Nonsmall Lung Cancer Treated With Nivolum... gan Atsuto Mouri, Hisao Imai, Satoshi Endo, Junichi Nakagawa, Kasumi Tsukamoto, Yuhei Kurata, Ou Yamaguchi, Kenji Masaki, Kosuke Hashimoto, Ayako Shiono, Yu Miura, Kunihiko Kobayashi, Kyoichi Kaira, Hiroshi Kagamu

Cael y testun llawn

Efficacy and Safety of First-Line Nivolumab Plus Ipilimumab in Patients with Postoperative Recurrent and Inoperable Non-Small Cell Lung Cancer: A Real-World Retrospective Observati... gan Yuhei Kurata, Atsuto Mouri, Hisao Imai, Satoshi Endo, Kasumi Tsukamoto, Kenji Masaki, Kosuke Hashimoto, Yu Miura, Ayako Shiono, Ou Yamaguchi, Junichi Nakagawa, Kyoichi Kaira, Kunihiko Kobayashi, Hiroshi Kagamu

Cael y testun llawn